研究課題/領域番号 |
22K13423
|
研究種目 |
若手研究
|
配分区分 | 基金 |
審査区分 |
小区分07050:公共経済および労働経済関連
|
研究機関 | 早稲田大学 |
研究代表者 |
富 蓉 早稲田大学, 商学学術院, 専任講師 (70805259)
|
研究期間 (年度) |
2022-04-01 – 2026-03-31
|
研究課題ステータス |
交付 (2022年度)
|
配分額 *注記 |
4,420千円 (直接経費: 3,400千円、間接経費: 1,020千円)
2025年度: 780千円 (直接経費: 600千円、間接経費: 180千円)
2024年度: 780千円 (直接経費: 600千円、間接経費: 180千円)
2023年度: 1,170千円 (直接経費: 900千円、間接経費: 270千円)
2022年度: 1,690千円 (直接経費: 1,300千円、間接経費: 390千円)
|
キーワード | generic drugs |
研究開始時の研究の概要 |
we aim to assess if the incentives influence physicians' and pharmacies' willingness to prescribe and dispense generics. Furthermore, we expect to determine (2) whether the policies encouraged physicians to prescribe generics; (3) whether the policies motivated pharmacists to dispense generics.
|
研究実績の概要 |
The objective of this project is to investigate the incentives that prescribing physicians and dispensing pharmacies face when using generic drugs, as well as how current polices have impacted prescription and dispensing behaviors for generic drug promotion. With three types of incentives that physicians and pharmacies face—patient welfare, financial gains, and psychological costs;we aim to (1) assess if the incentives influence physicians' and pharmacies' willingness to prescribe and dispense generics, and if so, how they respond differently to the incentives. Furthermore, by focusing in-depth on generic-promotion policies, we expect to determine (2) whether the policies encouraged physicians to prescribe generics; (3) whether the policies motivated pharmacists to dispense generics.
|
現在までの達成度 (区分) |
現在までの達成度 (区分)
3: やや遅れている
理由
Due to the pandemic situation, the research process was slightly delayed.
|
今後の研究の推進方策 |
In 2023, we will examine the physician incentives in generic usage and how Policy Set I will alter physician behavior. Policies implemented and modified since 2010 for physicians will offer exogenous variances for identification. We expect to complete the estimations by the end of Q4 of 2023 and will discuss the findings at the Japanese Economics Association Annual Meeting later in 2024. Paper submissions will start in Q2 of 2024.
|